BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  OZMOSI Launches A Global Clinical Trials Database To Transform Drug Development Forecasting

  September 11, 2017

   · 

  3 min read
• Drug Development

  GlaxoSmithKline Release: Positive Results From Pioneering Salford Lung Study In Asthma Published In The Lancet, And Presented At European Respiratory Congress

  September 11, 2017

   · 

  19 min read
• FDA

  Gecko Biomedical Receives CE Mark Approval For SETALUM Sealant

  September 11, 2017

   · 

  4 min read
• Business

  Synpromics Expands Facilities To Meet Demand For Revolutionary Gene Control Technology

  September 11, 2017

   · 

  3 min read
• Evolva Awarded Contract By U.S. Government To Advance Novel Pest Control Product

  September 11, 2017

   · 

  3 min read
• Bristol-Myers Squibb Release: Opdivo (Nivolumab) Demonstrates Superior Recurrence-Free Survival Versus Yervoy (Ipilimumab) For Patients With Resected High-Risk Melanoma In Phase III Checkmate -238 Study

  September 11, 2017

   · 

  1 min read
• Genesis Cancercare Queensland Is First In Asia-Pacific Region To Use Elekta’s Venezia Brachytherapy Applicator

  September 11, 2017

   · 

  2 min read
• Drug Development

  Viking Therapeutics Announces Results Of Gene Expression Analysis From In Vivo Study Of VK2809 In Non-Alcoholic Steatohepatitis (NASH)

  September 11, 2017

   · 

  5 min read
• Drug Development

  Advicenne Announces Positive Pivotal Phase III Clinical Data For ADV7103 In Adults And Children Suffering From Distal Renal Tubular Acidosis (dRTA)

  September 11, 2017

   · 

  4 min read
• Drug Development

  Progression-Free Survival Data From Echo-202 Trial Of Incyte’s Epacadostat In Combination With Keytruda (Pembrolizumab) Underscore Durability Of Response In Patients With Advanced Melanoma

  September 11, 2017

   · 

  8 min read